Cell Therapeutics (CTIC) Set to Announce Earnings on Wednesday
Cell Therapeutics (NASDAQ:CTIC) is scheduled to be posting its quarterly earnings results on Wednesday, October 30th. Parties that are interested in registering for the company’s conference call can do so using this link.
Cell Therapeutics (NASDAQ:CTIC) traded down 0.80% on Tuesday, hitting $1.85. 519,486 shares of the company’s stock traded hands. Cell Therapeutics has a one year low of $0.97 and a one year high of $3.14. The stock has a 50-day moving average of $1.10 and a 200-day moving average of $1.15. The company’s market cap is $199.3 million.
A number of analysts have recently weighed in on CTIC shares. Analysts at Janney Montgomery Scott initiated coverage on shares of Cell Therapeutics in a research note to investors on Tuesday. They set a “buy” rating on the stock. Analysts at Wells Fargo & Co. reiterated a “positive” rating on shares of Cell Therapeutics in a research note to investors on Monday, October 7th.
Cell Therapeutics, Inc develops, acquires and commercializes treatments for cancer. It focuses on building a biopharmaceutical company with a diversified portfolio of oncology drugs.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.